Gene · 2627
Papers4,364
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,364
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exercise-responsive circTSN as a potential systemic biomarker during COPD rehabilitation. | Front Med (Lausanne) | 2025 | 41416079 | PubTator, text mining | PubMed |
| Molecular and epistatic interactions between pioneer transcription factors shape nucleosome dynamics and cell differentiation. | Nat Commun | 2025 | 41372234 | PubTator, text mining | PubMed |
| D3Impute: Dropout-aware discrimination, distribution-aware modeling, and density-guide imputation for scRNA-seq data. | PLoS Comput Biol | 2025 | 41325426 | PubTator, text mining | PubMed |
| Molecular effects of transposable element sequences in mammalian cells. | Genome Biol | 2025 | 41299541 | PubTator, text mining | PubMed |
| Investigating Novel Biomarkers in Endometrial Cancer - A Study on RT-qPCR and Immunohistochemistry. | Iran J Allergy Asthma Immunol | 2025 | 41266266 | PubTator, text mining | PubMed |
| Beyond Tumor Suppression: The Multifaceted Functions of HOPX in Tissue Differentiation, Metabolism, and Immunity. | Cells | 2025 | 41227363 | PubTator, text mining | PubMed |
| Ginsenoside Rb1 attenuates erythropoietin-exacerbated vascular calcification in chronic kidney disease through BMP2-dependent Smad1/5/9 inhibition. | Cytojournal | 2025 | 41216233 | PubTator, text mining | PubMed |
| Prognostic Potential of Cancer-Associated Fibroblast Surface Markers and Their Specific DNA Methylation in Prostate Cancer. | Diagnostics (Basel) | 2025 | 41095652 | PubTator, text mining | PubMed |
| Repurposing dihydroartemisinin as a novel anticancer agent against colorectal cancer stem cells. | J Food Drug Anal | 2025 | 41066740 | PubTator, text mining | PubMed |
| Novel presentation of CACNA1C variant as neonatal complete atrioventricular block, heart failure and non-compaction cardiomyopathy with oligogenic influences. | J Electrocardiol | 2025 | 41056817 | PubTator, text mining | PubMed |
| Hypoxia and Multilineage Communication in 3D Organoids for Human Disease Modeling. | Biomimetics (Basel) | 2025 | 41002858 | PubTator, text mining | PubMed |
| Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance. | Cells | 2025 | 41002429 | PubTator, text mining | PubMed |
| The Colonic Crypt: Cellular Dynamics and Signaling Pathways in Homeostasis and Cancer. | Cells | 2025 | 41002393 | PubTator, text mining | PubMed |
| Ovarian Tumor FAK Inhibition Releases Omega-3 Fatty Acids Stimulating GATA6 Peritoneal Macrophage CXCL13 Production Enhancing Immunotherapy. | bioRxiv | 2025 | 41000740 | PubTator, text mining | PubMed |
| Role of glycolysis related genes in the pathogenesis of hemorrhoids and immune cell infiltration analysis. | Sci Rep | 2025 | 40998906 | PubTator, text mining | PubMed |
| Distinct spatial transcriptomic patterns of substantia Nigra in Parkinson disease and Parkinsonian subtype of multiple system atrophy. | Acta Neuropathol Commun | 2025 | 40993824 | PubTator, text mining | PubMed |
| Signaling Pathways in Human Blastocyst Development: From Molecular Mechanisms to In Vitro Optimization. | J Dev Biol | 2025 | 40981269 | PubTator, text mining | PubMed |
| QKI ensures splicing fidelity during cardiogenesis by engaging the U6 tri-snRNP to activate splicing at weak 5' splice sites. | bioRxiv | 2025 | 40950209 | PubTator, text mining | PubMed |
| SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer. | Cancer Res | 2025 | 40928937 | PubTator, text mining | PubMed |
| Stem cell-based human embryo models: current knowledge and open questions. | Stem Cell Res Ther | 2025 | 40877982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2627/papers?page=6